1. Home
  2. MEI vs LRMR Comparison

MEI vs LRMR Comparison

Compare MEI & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Methode Electronics Inc.

MEI

Methode Electronics Inc.

HOLD

Current Price

$8.50

Market Cap

312.7M

Sector

Technology

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$5.31

Market Cap

280.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEI
LRMR
Founded
1946
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.7M
280.0M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
MEI
LRMR
Price
$8.50
$5.31
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$11.50
$16.14
AVG Volume (30 Days)
339.5K
5.8M
Earning Date
03-05-2026
04-14-2026
Dividend Yield
2.27%
N/A
EPS Growth
49.14
N/A
EPS
N/A
N/A
Revenue
$908,300,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.24
N/A
52 Week Low
$5.08
$1.61
52 Week High
$10.97
$6.42

Technical Indicators

Market Signals
Indicator
MEI
LRMR
Relative Strength Index (RSI) 51.32 69.16
Support Level $8.42 $3.22
Resistance Level $8.61 $5.37
Average True Range (ATR) 0.41 0.44
MACD -0.07 0.29
Stochastic Oscillator 22.93 70.18

Price Performance

Historical Comparison
MEI
LRMR

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: